PFE compared with JNJ: revenue, margins and what each company keeps, and the suppliers and customers both name

PFEPfizer Inc

Mkt capRevenueRevenue

JNJJohnson & Johnson

Mkt capRevenueRevenue

Compare

PFEPfizer Inc

JNJJohnson & Johnson

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PFE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±3.3%▲+1.52%×0.45

Q1 FY26±3.5%▲+0.57%×0.17

Feb 3 '26±3.2%▼−3.34%×1.03

Q3 FY25±4.2%▼−1.46%×0.36

JNJ

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.1%▼−5.73%×1.84

Q2 FY26±2.9%▼−2.69%×0.93

= impliedPFE realized, solidJNJ realized, hatchedOne scale, both sides: full bar = 6%× = |realized| ÷ impliedSource: market data

Q1 FY26

±3.0%

▲+0.90%

×0.30

Jan 21 '26±2.8%▼−0.09%×0.04

PFEPfizer Inc

30.71▲+0.62%· post 31.10· delayed

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

JNJJohnson & Johnson

271.04▼−0.79%· post 270.72· delayed

After hoursNov 2 '26delayed

Mkt cap$657.7BRevenue$25.4BQ3 FY26Revenue$94.2BFY25

Compare

After hoursNov 2 '26delayed

PFEPfizer Inc

JNJJohnson & Johnson

30.71▲+0.62%post 31.10delayed

Price

271.04▼−0.79%post 270.72delayed

$174.0B

Mkt cap

$657.7B

Q2 FY26$15.0B

Revenue

$25.4BQ3 FY26

FY25$62.6B

Revenue

$94.2BFY25

PFE30.71▲+0.62%vsJNJ271.04▼−0.79%After hoursNov 2 '26delayed